What is needed for phage therapy to become a reality in Western medicine? (Q87432476)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059181 AND SRC:MED&resulttype=core&format=json

10 March 2020

title

What is needed for phage therapy to become a reality in Western medicine? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059181 AND SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

1

Harald Brüssow

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059181 AND SRC:MED&resulttype=core&format=json

10 March 2020

publication date

9 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059181 AND SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059181 AND SRC:MED&resulttype=core&format=json

10 March 2020

volume

434

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059181 AND SRC:MED&resulttype=core&format=json

10 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059181 AND SRC:MED&resulttype=core&format=json

10 March 2020

page(s)

138-142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059181 AND SRC:MED&resulttype=core&format=json

Bacteriophages reduce experimental contamination of hard surfaces, tomato, spinach, broccoli, and ground beef by Escherichia coli O157:H7

10 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Bacteriophage therapy to reduce salmonella colonization of broiler chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

7 January 2021

Phages of dairy bacteria

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Isolation of Escherichia coli bacteriophages from the stool of pediatric diarrhea patients in Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Bacteriophage lysins as effective antibacterials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Biochemical characterization and evaluation of cytotoxicity of antistaphylococcal chimeric protein P128.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Evaluation of lytic activity of staphylococcal bacteriophage Sb‐1 against freshly isolated clinical pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Bacteriophage resistance mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Intestinal colonization by enteroaggregative Escherichia coli supports long-term bacteriophage replication in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Clinical aspects of phage therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

The role of regulated clinical trials in the development of bacteriophage therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Analysis of the resistome of a multidrug-resistant NDM-1-producing Escherichia coli strain by high-throughput genome sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

A stable phage lysin (Cpl-1) dimer with increased antipneumococcal activity and decreased plasma clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

A bacteriolytic agent that detects and kills Bacillus anthracis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Engineered bacteriophage-defence systems in bioprocessing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

7 January 2021

Bacteriophage therapy

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

European regulatory conundrum of phage therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2012.09.015

10.1016/J.VIROL.2012.09.015

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23059181 AND SRC:MED&resulttype=core&format=json

10 March 2020

1 reference